DK140498C - - Google Patents

Info

Publication number
DK140498C
DK140498C DK145373A DK145373A DK140498C DK 140498 C DK140498 C DK 140498C DK 145373 A DK145373 A DK 145373A DK 145373 A DK145373 A DK 145373A DK 140498 C DK140498 C DK 140498C
Authority
DK
Denmark
Application number
DK145373A
Other languages
Danish (da)
Other versions
DK140498B (da
Inventor
H Nishimura
M Shimizu
H Uno
T Hirooka
Y Masuda
M Kurokawa
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2786572A external-priority patent/JPS5545545B2/ja
Priority claimed from JP2786672A external-priority patent/JPS5616154B2/ja
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of DK140498B publication Critical patent/DK140498B/da
Application granted granted Critical
Publication of DK140498C publication Critical patent/DK140498C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK145373AA 1972-03-17 1973-03-16 Analogifremgangsmåde til fremstilling af 3-substituerede 1,2-benzisoxazolderivater. DK140498B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2786572A JPS5545545B2 (cg-RX-API-DMAC7.html) 1972-03-17 1972-03-17
JP2786672A JPS5616154B2 (cg-RX-API-DMAC7.html) 1972-03-17 1972-03-17

Publications (2)

Publication Number Publication Date
DK140498B DK140498B (da) 1979-09-17
DK140498C true DK140498C (cg-RX-API-DMAC7.html) 1980-03-17

Family

ID=26365855

Family Applications (1)

Application Number Title Priority Date Filing Date
DK145373AA DK140498B (da) 1972-03-17 1973-03-16 Analogifremgangsmåde til fremstilling af 3-substituerede 1,2-benzisoxazolderivater.

Country Status (10)

Country Link
US (1) US3948928A (cg-RX-API-DMAC7.html)
AU (1) AU466970B2 (cg-RX-API-DMAC7.html)
CA (1) CA1025857A (cg-RX-API-DMAC7.html)
CH (1) CH577984A5 (cg-RX-API-DMAC7.html)
DK (1) DK140498B (cg-RX-API-DMAC7.html)
ES (1) ES412813A1 (cg-RX-API-DMAC7.html)
FR (1) FR2181831B1 (cg-RX-API-DMAC7.html)
GB (1) GB1416071A (cg-RX-API-DMAC7.html)
NL (1) NL168833C (cg-RX-API-DMAC7.html)
SE (1) SE381047B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673746A (en) * 1978-10-06 1987-06-16 Hoechst-Roussel Pharmaceuticals, Inc. 1,2-benzisoxazoloxyacetic acids and related compounds
US4728662A (en) * 1977-11-21 1988-03-01 Hoechst-Roussel Pharmaceuticals Inc. 1,2-benzisoxazoloxyacetic acids and related compounds
US4610988A (en) * 1982-04-09 1986-09-09 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl]-4-(substituted)piperazines useful for alleviating pain
US4536578A (en) * 1982-04-09 1985-08-20 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-(substituted)piperazines
US4609658A (en) * 1982-04-09 1986-09-02 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl]-4-(substituted) piperazines useful for reducing blood pressure
JPS58201770A (ja) * 1982-05-18 1983-11-24 Dainippon Pharmaceut Co Ltd α−置換−1,2−ベンズイソキサゾ−ル−3−酢酸エステル類並びにその酸付加塩類及び第4級アンモニウム塩類
WO2006082030A1 (en) * 2005-02-04 2006-08-10 Ctg Pharma S.R.L. New 4-aminoquinoline derivatives as antimalarials
DK1879573T3 (da) 2005-05-10 2013-02-25 Incyte Corp Modulatorer af indolamin 2,3-dioxygenase og fremgangsmåder til anvendelse deraf
ES2540561T3 (es) 2005-12-20 2015-07-10 Incyte Corporation N-hidroxiamidinoheterociclos como moduladores de indolamina 2,3-dioxigenasa
WO2007081335A1 (en) * 2006-01-12 2007-07-19 Merck & Co., Inc. Therapeutic compounds for treating dyslipidemic conditions
CL2007002650A1 (es) 2006-09-19 2008-02-08 Incyte Corp Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras.
US20080146624A1 (en) * 2006-09-19 2008-06-19 Incyte Corporation Amidines as modulators of indoleamine 2,3-dioxygenase
CA2663057C (en) * 2006-09-19 2015-12-08 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
US20080182882A1 (en) * 2006-11-08 2008-07-31 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
EP2152679A1 (en) * 2007-05-24 2010-02-17 NeuroSearch A/S Benzisoxazole derivatives as potassium channel modulators for the treatment of e.g. respiratory diseases, epilepsy and convulsions
CA3012229C (en) 2008-07-08 2020-11-10 Incyte Holdings Corporation 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
EP3744715A1 (en) 2013-11-08 2020-12-02 Incyte Holdings Corporation Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670497C3 (de) * 1967-06-06 1973-12-20 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt, Budapest Isochinohnderivate und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
CH577984A5 (cg-RX-API-DMAC7.html) 1976-07-30
AU5347973A (en) 1974-09-19
SE381047B (sv) 1975-11-24
CA1025857A (en) 1978-02-07
NL168833B (nl) 1981-12-16
GB1416071A (en) 1975-12-03
DK140498B (da) 1979-09-17
NL7303682A (cg-RX-API-DMAC7.html) 1973-09-19
NL168833C (nl) 1982-05-17
FR2181831A1 (cg-RX-API-DMAC7.html) 1973-12-07
US3948928A (en) 1976-04-06
AU466970B2 (en) 1975-11-13
FR2181831B1 (cg-RX-API-DMAC7.html) 1975-10-10
ES412813A1 (es) 1976-07-01

Similar Documents

Publication Publication Date Title
FR2181831B1 (cg-RX-API-DMAC7.html)
FR2175933A1 (cg-RX-API-DMAC7.html)
FR2176147A1 (cg-RX-API-DMAC7.html)
JPS4892214A (cg-RX-API-DMAC7.html)
JPS494033A (cg-RX-API-DMAC7.html)
JPS4982444A (cg-RX-API-DMAC7.html)
JPS4896320A (cg-RX-API-DMAC7.html)
JPS492084U (cg-RX-API-DMAC7.html)
JPS4893737U (cg-RX-API-DMAC7.html)
JPS4963360A (cg-RX-API-DMAC7.html)
JPS4922323U (cg-RX-API-DMAC7.html)
JPS4995738U (cg-RX-API-DMAC7.html)
JPS4970948A (cg-RX-API-DMAC7.html)
CH568307A5 (cg-RX-API-DMAC7.html)
AU480295A (cg-RX-API-DMAC7.html)
CH568124A5 (cg-RX-API-DMAC7.html)
CH563109A5 (cg-RX-API-DMAC7.html)
CH571105B5 (cg-RX-API-DMAC7.html)
CH566827A5 (cg-RX-API-DMAC7.html)
CH560949A5 (cg-RX-API-DMAC7.html)
CH573498A5 (cg-RX-API-DMAC7.html)
CH1291872A4 (cg-RX-API-DMAC7.html)
CH588722A5 (cg-RX-API-DMAC7.html)
CH576549B5 (cg-RX-API-DMAC7.html)
CH590341A5 (cg-RX-API-DMAC7.html)